Galectin Therapeutics Inc. (GALT) vs Sol-Gel Technologies Ltd. (SLGL)

A side-by-side comparison of Galectin Therapeutics Inc. and Sol-Gel Technologies Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — GALT vs SLGL

growth of $100 · dividends reinvested · last 9y
GALT -21.5% (-2.7%/yr)SLGL -42.1% (-5.9%/yr)GALT compounded faster over this window
050100150Start $1002020202220242026$79$58
GALT SLGL

GALT vs SLGL: by the numbers

  • •GALT is the larger company ($248M vs $247M market cap).
  • •Both run net losses; GALT's is the smaller (0.00% vs -910.14% net margin).

Metrics side by side

Valuation

MetricGALTSLGL
P/S ratioN/A137.75
P/B ratioN/A5.14

Profitability

MetricGALTSLGL
Gross margin0.00%100.00%
Operating margin0.00%-38.88%
Net margin0.00%-910.14%
ROEN/A-33.97%
ROIC-1718.59%-35.90%

Growth (annualized)

MetricGALTSLGL
Revenue CAGR (5Y)N/A17.19%
Total return CAGR (5Y)0.60%-4.19%

Frequently asked

How have GALT and SLGL total returns compared?
Over the past 5 years, GALT delivered 0.60% and SLGL delivered -4.19% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.